Focus on Branded Treatments : They highlight access to FDA-approved options such as Zepbound, Wegovy, and Ozempic
The GLP-1 RA are still under prescribed in developed and well-funded health care systems and are not even available in the most modern formulations in some parts of the world
Erbil D, Eren CY, Demirel C, Kucuker MU, Solaroglu I, Eser HY
These alternatives frequently demonstrate improved availability and reduced cost structures
Today LifeVantage is headed up by President and CEO Steve Fife (right)
These considerations highlight the need for future studies specifically designed to evaluate GLP-1RAs in patients at high risk of PsA, particularly those with subclinical inflammation or early musculoskeletal symptoms